Schedule 13G ownership disclosure

LA JOLLA PHARMACEUTICAL CO

Security class unavailable · CUSIP: 503459604

Event date: 2016-01-28

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
6.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-16-453820
Form type
SC 13G
Filer
LA JOLLA PHARMACEUTICAL CO
CIK
CIK 920465
Filed
Feb 08, 2016
Reporting period
Jan 28, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub